{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:43:39Z","timestamp":1793378619534,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2022YFC3401400"],"award-info":[{"award-number":["2022YFC3401400"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["BE2023834"],"award-info":[{"award-number":["BE2023834"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015796","name":"Shanghai Lingjun Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015796","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373105"],"award-info":[{"award-number":["82373105"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170935"],"award-info":[{"award-number":["32170935"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32561160090"],"award-info":[{"award-number":["32561160090"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32501236"],"award-info":[{"award-number":["32501236"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jconrel.2025.114324","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T23:37:42Z","timestamp":1760398662000},"page":"114324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P1","title":["Dual-sensitization nanoformulation combining glutamine metabolism inhibition and Fas\/FasL activation for enhanced colorectal cancer immunotherapy"],"prefix":"10.1016","volume":"388","author":[{"given":"Dan","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhe","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xindi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dangge","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huae","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114324_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15965","article-title":"Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism","volume":"8","author":"Biancur","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114324_bb0010","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1126\/science.aav2588","article-title":"Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion","volume":"366","author":"Leone","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114324_bb0015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev-pathmechdis-031521-041113","article-title":"Metabolism and colorectal Cancer","volume":"18","author":"Sedlak","year":"2023","journal-title":"Annu. Rev. Pathol.-Mech. Dis."},{"key":"10.1016\/j.jconrel.2025.114324_bb0020","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1038\/onc.2015.381","article-title":"ASCT2\/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer","volume":"35","author":"Van Geldermalsen","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2025.114324_bb0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-021-00491-w","article-title":"The adaptive transition of glioblastoma stem cells and its implications on treatments","volume":"6","author":"Wang","year":"2021","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.114324_bb0030","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.tibs.2018.05.003","article-title":"Amino acid transporters revisited: new views in health and disease","volume":"43","author":"Kandasamy","year":"2018","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jconrel.2025.114324_bb0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gutjnl-2024-332429","article-title":"Glutamine metabolic competition drives immunosuppressive reprogramming of intratumour GPR109A+ myeloid cells to promote liver cancer progression","volume":"74","author":"Yang","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2025.114324_bb0040","article-title":"Combinatorial targeting of glutamine metabolism and lysosomal-based lipid metabolism effectively suppresses glioblastoma","volume":"5","author":"Zhong","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.jconrel.2025.114324_bb0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13045-023-01453-1","article-title":"Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy","volume":"16","author":"Yang","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2025.114324_bb0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-bioeng-071516-044546","article-title":"Glutaminolysis: a Hallmark of Cancer metabolism","volume":"19","author":"Yang","year":"2017","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2025.114324_bb0055","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140100","article-title":"Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer","volume":"131","author":"Edwards","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.114324_bb0060","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.molcel.2020.10.015","article-title":"Inhibition of glutamine utilization synergizes with immune checkpoint inhibitor to promote antitumor immunity","volume":"80","author":"Byun","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2025.114324_bb0065","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.annonc.2023.05.010","article-title":"Prediction of response to immune checkpoint blockade in patients with metastatic colorectal cancer with microsatellite instability","volume":"34","author":"Ratovomanana","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2025.114324_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113865","article-title":"VPS9D1-AS1 antisense therapy via lipid nanoparticles reprograms cold tumors and enhances immunotherapy in colorectal cancer","volume":"384","author":"Yang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114324_bb0075","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1053\/j.gastro.2023.04.029","article-title":"Molecular profiling provides clinical insights into targeted and immunotherapies as well as colorectal cancer prognosis","volume":"165","author":"Guo","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2025.114324_bb0080","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.ccell.2024.08.019","article-title":"Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer","volume":"42","author":"Wang","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2025.114324_bb0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.52244","article-title":"Comparative effectiveness of immune checkpoint inhibitors vs chemotherapy in patients with metastatic colorectal Cancer with measures of microsatellite instability, mismatch repair, or tumor mutational burden","volume":"6","author":"Quintanilha","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jconrel.2025.114324_bb0090","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41586-022-04522-6","article-title":"Androgen receptor activity in T cells limits checkpoint blockade efficacy","volume":"606","author":"Guan","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114324_bb0095","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12943-024-02166-w","article-title":"Cellular mechanisms of combining innate immunity activation with PD-1\/PD-L1 blockade in treatment of colorectal cancer","volume":"23","author":"Xie","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2025.114324_bb0100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12943-024-02179-5","article-title":"Current trends in sensitizing immune checkpoint inhibitors for cancer treatment","volume":"23","author":"Wei","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2025.114324_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202309094","article-title":"A PD-L1-targeting regulator for metabolic reprogramming to enhance glutamine inhibition-mediated synergistic antitumor metabolic and immune therapy","volume":"36","author":"Jin","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114324_bb0110","doi-asserted-by":"crossref","first-page":"eabq5925","DOI":"10.1126\/sciadv.abq5925","article-title":"Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug","volume":"8","author":"Rais","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2025.114324_bb0115","article-title":"Inhibition of glutamate-to-glutathione flux promotes tumor antigen presentation in colorectal cancer cells","volume":"12","author":"Yu","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.114324_bb0120","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41577-023-00973-8","article-title":"Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations","volume":"24","author":"Butterfield","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114324_bb0125","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/s41573-023-00809-z","article-title":"T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome","volume":"22","author":"Klebanoff","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.114324_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113726","article-title":"Soluble-microneedle enhance three T-cell activation signals as efficient tumor vaccines for melanoma prevention and treatment","volume":"383","author":"Li","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114324_bb0135","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1158\/2159-8290.CD-20-0756","article-title":"A critical role for fas-mediated off-target tumor killing in T-cell immunotherapy","volume":"11","author":"Upadhyay","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2025.114324_bb0140","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1158\/2159-8290.CD-19-0813","article-title":"Impaired death receptor signaling in leukemia causes antigen-independent resistance by inducing CAR T-cell dysfunction","volume":"10","author":"Singh","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2025.114324_bb0145","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1038\/s41418-023-01229-7","article-title":"Characterizing the regulatory Fas (CD95) epitope critical for agonist antibody targeting and CAR-T bystander function in ovarian cancer","volume":"30","author":"Mondal","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2025.114324_bb0150","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1126\/science.adg1955","article-title":"Hyperglycosylation of prosaposin in tumor dendritic cells drives immune escape","volume":"383","author":"Zhan","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114324_bb0155","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","article-title":"Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity","volume":"24","author":"Meier","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.114324_bb0160","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jconrel.2023.04.027","article-title":"Targeting glutamine metabolism with photodynamic immunotherapy for metastatic tumor eradication","volume":"357","author":"Zhao","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114324_bb0165","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.scib.2024.04.014","article-title":"Hepatitis B virus core protein as a Rab-GAP suppressor driving liver disease progression","volume":"69","author":"Su","year":"2024","journal-title":"Sci. Bull."},{"key":"10.1016\/j.jconrel.2025.114324_bb0170","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/364806a0","article-title":"Lethal effect of the anti-Fas antibody in mice","volume":"364","author":"Ogasawara","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114324_bb0175","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.abq6990","article-title":"The future of engineered immune cell therapies","volume":"378","author":"Irvine","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114324_bb0180","doi-asserted-by":"crossref","first-page":"eaba7365","DOI":"10.1126\/science.aba7365","article-title":"CRISPR-engineered T cells in patients with refractory cancer","volume":"367","author":"Stadtmauer","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114324_bb0185","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/s41467-025-56527-0","article-title":"Unlocking the potential of engineered immune cell therapy for solid tumors","volume":"16","author":"Albarr\u00e1n-Fern\u00e1ndez","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114324_bb0190","doi-asserted-by":"crossref","first-page":"eadl4237","DOI":"10.1126\/science.adl4237","article-title":"Programming tissue-sensing T cells that deliver therapies to the brain","volume":"386","author":"Simic","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114324_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202407525","article-title":"Delivery systems developed for treatment combinations to improve adoptive cell therapy","volume":"36","author":"Xu","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114324_bb0200","article-title":"CXCL9\/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer","volume":"5","author":"Lim","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.jconrel.2025.114324_bb0205","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41586-023-06299-8","article-title":"SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity","volume":"620","author":"Guo","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114324_bb0210","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.eururo.2018.09.030","article-title":"Tumor-associated macrophage-derived Interleukin-23 interlinks kidney Cancer glutamine addiction with immune evasion","volume":"75","author":"Fu","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jconrel.2025.114324_bb0215","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nm.4464","article-title":"Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models","volume":"24","author":"Schulte","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.114324_bb0220","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.chroma.2005.11.129","article-title":"Simultaneous quantification of reduced and oxidized glutathione in plasma using a two-dimensional chromatographic system with parallel porous graphitized carbon columns coupled with fluorescence and coulometric electrochemical detection","volume":"1104","author":"Sakhi","year":"2006","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jconrel.2025.114324_bb0225","doi-asserted-by":"crossref","first-page":"9530","DOI":"10.1016\/S0021-9258(18)43421-7","article-title":"Dynamic state of glutathione in blood plasma","volume":"255","author":"Anderson","year":"1980","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2025.114324_bb0230","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41580-023-00645-4","article-title":"Understanding mechanisms of antioxidant action in health and disease","volume":"25","author":"Halliwell","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2025.114324_bb0235","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/mm9.0000000000000004","article-title":"Metalloptosis: metal ions-induced programmed cell death based on nanomaterials for cancer therapy","volume":"1","author":"Wang","year":"2024","journal-title":"MedMat"},{"key":"10.1016\/j.jconrel.2025.114324_bb0240","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.114324_bb0245","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ccell.2024.11.011","article-title":"Cytokines in cancer","volume":"43","author":"Kureshi","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2025.114324_bb0250","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/cells10010100","article-title":"Inflammatory cytokines in cancer: comprehensive understanding and clinical progress in gene therapy","volume":"10","author":"Lan","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2025.114324_bb0255","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1200\/JCO.2021.39.15_suppl.2584","article-title":"IFN-\u03b1, IFN-\u03b3, IL-2 combined with TNF-\u03b1 for predicting efficacy of PD-1 inhibitors combination therapy in patients with solid cancers","volume":"39","author":"Xing","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.114324_bb0260","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","article-title":"Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-\u03b1","volume":"35","author":"Wu","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2025.114324_bb0265","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.immuni.2018.09.024","article-title":"Successful anti-PD-1 Cancer immunotherapy requires T cell-dendritic cell crosstalk involving the cytokines IFN-\u03b3 and IL-12","volume":"49","author":"Garris","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.114324_bb0270","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.cell.2023.12.015","article-title":"Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death","volume":"187","author":"Li","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.114324_bb0275","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12967-018-1611-7","article-title":"Unleashing endogenous TNF-alpha as a cancer immunotherapeutic","volume":"16","author":"Josephs","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114324_bb0280","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","article-title":"Loss of IFN-\u03b3 pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy","volume":"167","author":"Gao","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2025.114324_bb0285","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2017-314924","article-title":"Guidelines on the management of abnormal liver blood tests","volume":"67","author":"Newsome","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2025.114324_bb0290","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202402479","article-title":"Gold nanoparticle transport in the injured kidneys with elevated renal function biomarkers","volume":"36","author":"Ning","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114324_bb0295","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ejhf.3114","article-title":"Independent prognostic importance of blood urea nitrogen to creatinine ratio in heart failure","volume":"26","author":"Tolomeo","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jconrel.2025.114324_bb0300","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10572","article-title":"Common and rare variants associating with serum levels of creatine kinase and lactate dehydrogenase","volume":"7","author":"Kristjansson","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114324_bb0305","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nbt.4181","article-title":"Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery","volume":"36","author":"Tang","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114324_bb0310","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/s41565-021-00972-7","article-title":"T lymphocyte membrane-decorated epigenetic nanoinducer of interferons for cancer immunotherapy","volume":"16","author":"Zhai","year":"2021","journal-title":"Nat. Nanotechnol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:59:16Z","timestamp":1773190756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925009381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":62,"alternative-id":["S0168365925009381"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114324","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-sensitization nanoformulation combining glutamine metabolism inhibition and Fas\/FasL activation for enhanced colorectal cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114324"}}